Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Xu, Ya Fei ^a   Liu, Wan Li ^a   Dong, Ju Qin ^a   Liu, Wen Sheng ^a   Feng, Qi Sheng ^a   Chen, Li Zhen ^a   Zeng, Yi Xin ^a   Zeng, Mu Sheng ^a   Jia, Wei Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHI SQUARE TEST; CHINA; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NASOPHARYNX TUMOR; RISK;

ADULT; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; LECTINS, C-TYPE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; RISK;

EID: 78149286932     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-161     Document Type: Article

References (53)

1. Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002, 31(4):395-399.
2. Ou SH, Zell JA, Ziogas A, Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 2007, 18(1):29-35. 10.1093/annonc/mdl320, 17060483.
3. Ng WT, Choi CW, Lee MC, Chan SH, Yau TK, Lee AW. Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening. Fam Cancer 2009, 8(2):103-108. 10.1007/s10689-008-9213-9, 18726711.
4. Takeshita H, Furukawa M, Fujieda S, Shoujaku H, Ookura T, Sakaguchi M, Ito H, Mineta H, Harada T, Matsuura H, et al. Epidemiological research into nasopharyngeal carcinoma in the Chubu region of Japan. Auris Nasus Larynx 1999, 26(3):277-286. 10.1016/S0385-8146(98)00080-7, 10419035.
5. Busson P, Ooka T, Corbex M. Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy. Med Sci (Paris) 2004, 20(4):453-457.
6. Pattle SB, Farrell PJ. The role of Epstein-Barr virus in cancer. Expert Opin Biol Ther 2006, 6(11):1193-1205. 10.1517/14712598.6.11.1193, 17049016.
7. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002, 12(6):431-441. 10.1016/S1044579X0200086X, 12450729.
8. Rickinson ABKE. Epstein-Barr virus. Field's virology 2001, 2575-2627. Philadelphia (Pennsylvania): Lippincott,Williams & Wilkins, Knipe DM, Howley PM, 4.
9. Pepperl S, Benninger-Doring G, Modrow S, Wolf H, Jilg W. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes. J Virol 1998, 72(11):8644-8649. 110276, 9765404.
10. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000, 343(7):481-492. 10.1056/NEJM200008173430707, 10944566.
11. Feng P, Ren EC, Liu D, Chan SH, Hu H. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. J Gen Virol 2000, 81(Pt 10):2417-2423.
12. Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 2000, 165(6):2937-2942.
13. Tailleux L, Pham-Thi N, Bergeron-Lafaurie A, Herrmann JL, Charles P, Schwartz O, Scheinmann P, Lagrange PH, de Blic J, Tazi A, et al. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis. PLoS Med 2005, 2(12):e381. 10.1371/journal.pmed.0020381, 1283365, 16279841.
14. Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, Amara A, Legres L, Dreher D, Nicod LP, Gluckman JC, et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003, 197(1):121-127. 10.1084/jem.20021468, 2193794, 12515819.
15. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100(5):575-585. 10.1016/S0092-8674(00)80693-5, 10721994.
16. Soilleux EJ, Morris LS, Leslie G, Chehimi J, Luo Q, Levroney E, Trowsdale J, Montaner LJ, Doms RW, Weissman D, et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002, 71(3):445-457.
17. Geijtenbeek TB, van Vliet SJ, Engering A, t Hart BA, van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 2004, 22:33-54. 10.1146/annurev.immunol.22.012703.104558, 15032573.
18. Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, Wirth HP, Kapsenberg ML, Vandenbroucke-Grauls CM, van Kooyk Y, Appelmelk BJ. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 2004, 200(8):979-990. 10.1084/jem.20041061, 2211851, 15492123.
19. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100(5):587-597. 10.1016/S0092-8674(00)80694-7, 10721995.
20. Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 2002, 76(13):6841-6844. 10.1128/JVI.76.13.6841-6844.2002, 136246, 12050398.
21. Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305(1):115-123. 10.1006/viro.2002.1730, 12504546.
22. Halary F, Amara A, Lortat-Jacob H, Messerle M, Delaunay T, Houles C, Fieschi F, Arenzana-Seisdedos F, Moreau JF, Dechanet-Merville J. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002, 17(5):653-664. 10.1016/S1074-7613(02)00447-8, 12433371.
23. Lozach PY, Amara A, Bartosch B, Virelizier JL, Arenzana-Seisdedos F, Cosset FL, Altmeyer R. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 2004, 279(31):32035-32045. 10.1074/jbc.M402296200, 15166245.
24. Pohlmann S, Zhang J, Baribaud F, Chen Z, Leslie GJ, Lin G, Granelli-Piperno A, Doms RW, Rice CM, McKeating JA. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003, 77(7):4070-4080. 10.1128/JVI.77.7.4070-4080.2003, 150620, 12634366.
25. Despres P, Sakuntabhai A, Julier C. [A variant in the CD209 (DC-SIGN) promoter is associated with severity of dengue disease]. Med Sci (Paris) 2005, 21(11):905-906.
26. Marzi A, Gramberg T, Simmons G, Moller P, Rennekamp AJ, Krumbiegel M, Geier M, Eisemann J, Turza N, Saunier B, et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 2004, 78(21):12090-12095. 10.1128/JVI.78.21.12090-12095.2004, 523257, 15479853.
27. Colmenares M, Puig-Kroger A, Pello OM, Corbi AL, Rivas L. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J Biol Chem 2002, 277(39):36766-36769. 10.1074/jbc.M205270200, 12122001.
28. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003, 197(7):823-829. 10.1084/jem.20021840, 2193896, 12682107.
29. Vannberg FO, Chapman SJ, Khor CC, Tosh K, Floyd S, Jackson-Sillah D, Crampin A, Sichali L, Bah B, Gustafson P, et al. CD209 genetic polymorphism and tuberculosis disease. PLoS One 2008, 3(1):e1388. 10.1371/journal.pone.0001388, 2148105, 18167547.
30. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, McElreavey K, Helden PD, Hoal EG, Gicquel B, Quintana-Murci L. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 2006, 3(2):e20. 10.1371/journal.pmed.0030020, 1324949, 16379498.
31. Koizumi Y, Kageyama S, Fujiyama Y, Miyashita M, Lwembe R, Ogino K, Shioda T, Ichimura H. RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. AIDS Res Hum Retroviruses 2007, 23(5):713-719. 10.1089/aid.2006.0225, 17530998.
32. Martin MP, Lederman MM, Hutcheson HB, Goedert JJ, Nelson GW, van Kooyk Y, Detels R, Buchbinder S, Hoots K, Vlahov D, et al. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 2004, 78(24):14053-14056. 10.1128/JVI.78.24.14053-14056.2004, 533922, 15564514.
33. Geijtenbeek TB, van Kooyk Y. DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. Curr Top Microbiol Immunol 2003, 276:31-54.
34. Nunez C, Rueda B, Martinez A, Maluenda C, Polanco I, Lopez-Nevot MA, Ortega E, Sierra E, Gomez de la Concha E, Urcelay E, et al. A functional variant in the CD209 promoter is associated with DQ2-negative celiac disease in the Spanish population. World J Gastroenterol 2006, 12(27):4397-4400.
35. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005, 37(5):507-513. 10.1038/ng1550, 15838506.
36. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
37. Kashima S, Rodrigues ES, Azevedo R, da Cruz Castelli E, Mendes-Junior CT, Yoshioka FK, da Silva IT, Takayanagui OM, Covas DT. DC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infection. J Gen Virol 2009, 90(Pt 4):927-934. 10.1099/vir.0.008367-0, 2885039, 19264667.
38. Boily-Larouche G, Zijenah LS, Mbizvo M, Ward BJ, Roger M. DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: potential implications for pathogen recognition and disease susceptibility. Hum Immunol 2007, 68(6):523-530. 10.1016/j.humimm.2007.02.002, 17509452.
39. Nunez C, Oliver J, Mendoza JL, Gomez-Garcia M, Taxonera C, Gomez LM, Lopez-Nevot MA, de la Concha EG, Urcelay E, Martinez A, et al. CD209 in inflammatory bowel disease: a case-control study in the Spanish population. BMC Med Genet 2007, 8:75. 10.1186/1471-2350-8-75, 2241584, 18070336.
40. Ben-Ali M, Barreiro LB, Chabbou A, Haltiti R, Braham E, Neyrolles O, Dellagi K, Gicquel B, Quintana-Murci L, Barbouche MR. Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients. Hum Immunol 2007, 68(11):908-912. 10.1016/j.humimm.2007.09.003, 18082570.
41. Becker Y. Immunological and regulatory functions of uninfected and virus infected immature and mature subtypes of dendritic cells--a review. Virus Genes 2003, 26(2):119-130. 10.1023/A:1023427228024, 12803463.
42. Kobelt D, Lechmann M, Steinkasserer A. The interaction between dendritic cells and herpes simplex virus-1. Curr Top Microbiol Immunol 2003, 276:145-161.
43. Schneider-Schaulies S, Klagge IM, ter Meulen V. Dendritic cells and measles virus infection. Curr Top Microbiol Immunol 2003, 276:77-101.
44. Sevilla N, Kunz S, McGavern D, Oldstone MB. Infection of dendritic cells by lymphocytic choriomeningitis virus. Curr Top Microbiol Immunol 2003, 276:125-144.
45. Li L, Liu D, Hutt-Fletcher L, Morgan A, Masucci MG, Levitsky V. Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 2002, 99(10):3725-3734. 10.1182/blood.V99.10.3725, 11986229.
46. Savard M, Belanger C, Tardif M, Gourde P, Flamand L, Gosselin J. Infection of primary human monocytes by Epstein-Barr virus. J Virol 2000, 74(6):2612-2619. 10.1128/JVI.74.6.2612-2619.2000, 111749, 10684275.
47. Masy E, Adriaenssens E, Montpellier C, Crepieux P, Mougel A, Quatannens B, Goormachtigh G, Faumont N, Meggetto F, Auriault C, et al. Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation. J Virol 2002, 76(13):6460-6472. 10.1128/JVI.76.13.6460-6472.2002, 136267, 12050358.
48. Schlitt A, Blankenberg S, Weise K, Gartner BC, Mehrer T, Peetz D, Meyer J, Darius H, Rupprecht HJ. Herpesvirus DNA (Epstein-Barr virus, herpes simplex virus, cytomegalovirus) in circulating monocytes of patients with coronary artery disease. Acta Cardiol 2005, 60(6):605-610. 10.2143/AC.60.6.2004932, 16385921.
49. Ochoa MT, Loncaric A, Krutzik SR, Becker TC, Modlin RL. "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J Invest Dermatol 2008, 128(9):2225-2231. 10.1038/jid.2008.56, 2682223, 18337829.
50. Guerreiro-Cacais AO, Li L, Donati D, Bejarano MT, Morgan A, Masucci MG, Hutt-Fletcher L, Levitsky V. Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication. J Gen Virol 2004, 85(Pt 10):2767-2778. 10.1099/vir.0.80140-0, 15448337.
51. Shimakage M, Kimura M, Yanoma S, Ibe M, Yokota S, Tsujino G, Kozuka T, Dezawa T, Tamura S, Ohshima A, et al. Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch Virol 1999, 144(1):157-166. 10.1007/s007050050492, 10076516.
52. Baumann J, Park CG, Mantis NJ. Recognition of secretory IgA by DC-SIGN: implications for immune surveillance in the intestine. Immunol Lett 2010, 131(1):59-66. 10.1016/j.imlet.2010.03.005, 20362001.
53. Sixbey JW, Yao QY. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 1992, 255(5051):1578-1580. 10.1126/science.1312750, 1312750.